133 related articles for article (PubMed ID: 23672314)
1. Expression of Ep-CAM, but not of E48, associates with nodal involvement in advanced squamous cell carcinomas of the larynx.
Romeu C; Farré X; Cardesa A; Nadal A
Histopathology; 2013 May; 62(6):954-61. PubMed ID: 23672314
[TBL] [Abstract][Full Text] [Related]
2. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
Piyathilake CJ; Frost AR; Weiss H; Manne U; Heimburger DC; Grizzle WE
Hum Pathol; 2000 Apr; 31(4):482-7. PubMed ID: 10821496
[TBL] [Abstract][Full Text] [Related]
3. [Study of cell adhesion in cancer of the larynx].
Romeu Figuerola C; Nadal Serra A; Farré Pueyo X; Palomar García V
Acta Otorrinolaringol Esp; 2000 May; 51(4):288-92. PubMed ID: 10984950
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of E-cadherin and Ep-CAM in cervical lymph node metastasis of supraglottic larynx carcinoma.
Ali Bayram ; Yüce İ; Çağlı S; Canöz Ö; Güney E
Am J Otolaryngol; 2015; 36(6):736-40. PubMed ID: 26545462
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
6. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker.
Stoecklein NH; Siegmund A; Scheunemann P; Luebke AM; Erbersdobler A; Verde PE; Eisenberger CF; Peiper M; Rehders A; Esch JS; Knoefel WT; Hosch SB
BMC Cancer; 2006 Jun; 6():165. PubMed ID: 16796747
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation.
Litvinov SV; van Driel W; van Rhijn CM; Bakker HA; van Krieken H; Fleuren GJ; Warnaar SO
Am J Pathol; 1996 Mar; 148(3):865-75. PubMed ID: 8774141
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.
Alberti S; Ambrogi F; Boracchi P; Fornili M; Querzoli P; Pedriali M; La Sorda R; Lattanzio R; Tripaldi R; Piantelli M; Biganzoli E; Coradini D
Jpn J Clin Oncol; 2012 Dec; 42(12):1128-37. PubMed ID: 23072840
[TBL] [Abstract][Full Text] [Related]
9. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
[TBL] [Abstract][Full Text] [Related]
10. Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver.
de Boer CJ; van Krieken JH; Janssen-van Rhijn CM; Litvinov SV
J Pathol; 1999 Jun; 188(2):201-6. PubMed ID: 10398165
[TBL] [Abstract][Full Text] [Related]
11. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer.
Takes RP; Baatenburg de Jong RJ; Wijffels K; Schuuring E; Litvinov SV; Hermans J; van Krieken JH
J Pathol; 2001 Jul; 194(3):298-302. PubMed ID: 11439361
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of Ep-CAM and cyclin D1 and their clinical significance in gallbladder carcinoma].
Ren G; Yu G; Liu LW; Ma L
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):841-4. PubMed ID: 20137349
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
Joo M; Kim H; Kim MK; Yu HJ; Kim JP
J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
[TBL] [Abstract][Full Text] [Related]
14. MOC-31/Ep-CAM immunoreactivity in Merkel cells and Merkel cell carcinomas.
García-Caballero T; Pintos E; Gallego R; Parrado C; Blanco M; Bjornhagen V; Forteza J; Beiras A
Histopathology; 2003 Nov; 43(5):480-4. PubMed ID: 14636274
[TBL] [Abstract][Full Text] [Related]
15. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.
Schmidt M; Hasenclever D; Schaeffer M; Boehm D; Cotarelo C; Steiner E; Lebrecht A; Siggelkow W; Weikel W; Schiffer-Petry I; Gebhard S; Pilch H; Gehrmann M; Lehr HA; Koelbl H; Hengstler JG; Schuler M
Clin Cancer Res; 2008 Sep; 14(18):5849-55. PubMed ID: 18794096
[TBL] [Abstract][Full Text] [Related]
16. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.
Winter MJ; Nagtegaal ID; van Krieken JH; Litvinov SV
Am J Pathol; 2003 Dec; 163(6):2139-48. PubMed ID: 14633587
[TBL] [Abstract][Full Text] [Related]
17. Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17-1A and BerEP4.
Brezicka T
Acta Oncol; 2005; 44(7):723-7. PubMed ID: 16227163
[TBL] [Abstract][Full Text] [Related]
18. Relationships between immunophenotype, Ki-67 index, microvascular density, Ep-CAM/P-cadherin, and MMP-2 expression in early-stage invasive ductal breast cancer.
Niemiec JA; Adamczyk A; Małecki K; Majchrzyk K; Ryś J
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):550-60. PubMed ID: 22531681
[TBL] [Abstract][Full Text] [Related]
19. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.
Spizzo G; Went P; Dirnhofer S; Obrist P; Simon R; Spichtin H; Maurer R; Metzger U; von Castelberg B; Bart R; Stopatschinskaya S; Köchli OR; Haas P; Mross F; Zuber M; Dietrich H; Bischoff S; Mirlacher M; Sauter G; Gastl G
Breast Cancer Res Treat; 2004 Aug; 86(3):207-13. PubMed ID: 15567937
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression.
Tai KY; Shiah SG; Shieh YS; Kao YR; Chi CY; Huang E; Lee HS; Chang LC; Yang PC; Wu CW
Oncogene; 2007 Jun; 26(27):3989-97. PubMed ID: 17213811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
